HIMS
Hims Hers Health Inc
NYSE: HIMS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$30.56
+8.56% today
Updated 2026-04-24
Market cap
$6.78B
P/E ratio
58.35
P/S ratio
2.89x
EPS (TTM)
$0.51
Dividend yield
—
52W range
$14 – $70
Volume
39.1M
WallStSmart proprietary scores
50
out of 100
Grade: C
Hold
Investment rating
6.7
Growth
B4.5
Quality
C6.0
Profitability
B4.0
Valuation
C2/9
Piotroski F-Score
Weak
1.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$24.31
-20.45%
12-Month target
$15.27
-50.03%
Intrinsic (DCF)
$39.63
Margin of safety
+24.91%
2 Strong Buy1 Buy12 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 25.20% — strong efficiency
+ Free cash flow $821000.00 — positive
+ Revenue growth 28.40% QoQ
+ 24.91% below intrinsic value
Risks
- Piotroski 2/9 — weak financial health
- Altman Z 1.58 — distress zone
- P/E 58.35x — expensive valuation
- Debt/equity 2.34x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $526.92M | $872.00M | $1.48B | $2.35B | $2.35B | $2.8B |
| Net income | $-65.68M | $-23.55M | $126.04M | $128.37M | $20.60M | — |
| EPS | — | — | — | — | $0.51 | $0.58 |
| Free cash flow | $-33.78M | $46.99M | $198.33M | $73.96M | $821000.00 | — |
| Profit margin | -12.46% | -2.70% | 8.54% | 5.47% | 5.47% | — |
Peer comparison
Smart narrative
Hims Hers Health Inc trades at $30.56. representing a P/E of 58.35x trailing earnings. Our Smart Value Score of 50/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 1.58, it sits in the distress. TTM revenue stands at $2.35B. with profit margins at 5.47%. Our DCF model estimates intrinsic value at $39.63.
Frequently asked questions
What is Hims Hers Health Inc's stock price?
Hims Hers Health Inc (HIMS) trades at $30.56.
Is Hims Hers Health Inc overvalued?
Smart Value Score 50/100 (Grade C, Hold). DCF value $39.63.
What is the price target of Hims Hers Health Inc (HIMS)?
The analyst target price is $24.31, representing -20.5% downside from the current price of $30.56.
What is the intrinsic value of Hims Hers Health Inc (HIMS)?
Based on our DCF model, intrinsic value is $39.63, a +24.9% margin of safety versus $30.56.
What is the future stock price of HIMS by 2030?
Our research-backed model estimates Hims Hers Health Inc could reach $77.53 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Hims Hers Health Inc's revenue?
TTM revenue is $2.35B.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
1.58 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio2.89x
ROE25.20%
Beta2.32
50D MA$20.21
200D MA$38.20
Shares out0.22B
Float0.21B
Short ratio—
Avg volume39.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—